Autologous stem-cell transplant for metastatic renal medullary carcinoma

Pediatr Blood Cancer. 2018 Sep;65(9):e27267. doi: 10.1002/pbc.27267. Epub 2018 Jun 1.

Authors

Marcus A Carden¹, Eva Perdahl-Wallace², Jay Greenberg³, John M McCarty⁴

Affiliations

¹ Aflac Cancer and Blood Disorders Center, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.
² Pediatric Hematology/Oncology, Kaiser Permanente of the Mid-Atlantic States, Washington, District of Columbia.
³ Divison of Hematology/Oncology, Children's National Medical Center, Washington, District of Columbia.
⁴ Division of Hematology/Oncology, Virginia Commonwealth University School of Medicine, Richmond, Virginia.

PMID: 29856525
DOI: 10.1002/pbc.27267

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Renal Cell / complications
Carcinoma, Renal Cell / secondary*
Carcinoma, Renal Cell / therapy
Cisplatin / administration & dosage
Doxorubicin / administration & dosage
Etoposide / administration & dosage
Humans
Ifosfamide / administration & dosage
Kidney Neoplasms / complications
Kidney Neoplasms / drug therapy
Kidney Neoplasms / surgery
Lung Neoplasms / complications
Lung Neoplasms / secondary*
Lung Neoplasms / therapy
Male
Nephrectomy
Paclitaxel / administration & dosage
Peripheral Blood Stem Cell Transplantation*
Sickle Cell Trait / complications
Transplantation, Autologous

Substances

Etoposide
Doxorubicin
Paclitaxel
Cisplatin
Ifosfamide